Common Cardiovascular Drugs

Slides:



Advertisements
Similar presentations
Inotropes in Cardiac Surgery
Advertisements

Dr Bronwyn Avard, July 2010  To understand the basic physiology of shock  To understand the pharmacodynamics and pharmacokinetics of vasoactive drugs.
Agents used in therapy of Congestive Heart Failure
Emergency Department Patient Hypertensive Emergencies: What treatment modalities do emergency physicians utilize in the ED?
Sean Forsythe M.D. Assistant Professor of Medicine
Drug profile DOBUTAMINE. injection 250 mg per 5 ml ampule Store away from light & moisture at 15-30C(59-86F) Brand Name Manufacture Dosage Form Strength.
Antiarrhythmic Agents: Cardiac Stimulants and Depressants
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 8 Xanthines.
1 Copyright © 2012, 2008, 2002, 1998, 1994, 1989, 1984, 1978 by Mosby, Inc., an affiliate of Elsevier Inc. Reminder:  QUIZ NEXT WEEK ON:  Anti-infectives,
CHAPTER II: CARDIAC MECHANICS Asst. Prof. Dr. Emre Hamurtekin EMU Faculty of Pharmacy.
Pharmacologic Management of Acute Circulatory Failure Suanne M. Daves, M.D. Associate Professor Department of Pediatrics.
Cardiovascular Medications PICU Resident Talk Stanford School of Medicine Pediatric Critical Care Medicine June 2010.
Treating Hemodynamic Disturbances and Threats to Tissue Oxygenation: A Review of Commonly Used PIC/NIC Medications Julie Warren RN, MSN, CCRN Pediatric.
1 Cardiac Pathophysiology Part B. 2 Heart Failure The heart as a pump is insufficient to meet the metabolic requirements of tissues. Can be due to: –
ProCalc Nsg 231 Calculating IV prescribed drug dose in ml/hr Example 1 An IV of dextrose 5% in water containing 2 mg of Isuprel (isoproterenol) and a.
Cardiovascular management
Chapter 18 Agents that Dilate Blood Vessels. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Coronary.
MEDICATIONS. Medications Epinephrine Volume expanders Sodium bicarbonate Naloxone Dopamine.
PHARMAKOLOGY VASOPRESSOR DRUGS DJUDJUK RAHMAD BASUKI Lab.Anestesi dan Terapi Intensive RSSA Malang.
Vasoactive Drugs and Shock
OBJECTIVES At the end of lectures the students should Describe the different classes of drugs used for treatment of acute & chronic heart failure.
Drugs for Congestive Heart Failure
Sympathomimetics (continue)
Calcium Channel Blockers and Digitalis. Dig Ca Channel Blockers.
1 Drug Treatment of heart failure. Prof. Azza El-Medani Prof. Abdulrahman Almotrefi.
Vasoactive Agents in the PICU
Vasopressors.
BIMM118 Angina pectoris Medical term for chest pain or discomfort due to coronary heart disease. Typical angina pectoris (=“tight heart” is uncomfortable.
for more lecture notes Antianginal Agents Dr.Shadi-Sarahroodi Pharm.D & PhD Qom University of Medical sciences Iran PUBLISHED.
Heart failure Dr Rafat Mosalli. Objectives Definition Definition Pathophysiology Pathophysiology Age specific Causes Age specific Causes Clinical pictures.
PROF. AZZA El-Medany Department of Pharmacology OBJECTIVES At the end of lectures the students should Describe the different classes of drugs used for.
Bipyridines :(Amrinone,Milrinone ) only available in parenteral form. Half-life 3-6hrs. Excreted in urine.
PICU Resident Talk Stanford School of Medicine Pediatric Critical Care Medicine June 2014.
Antianginal drugs Angina pectoris is the severe chest pain that occurs when coronary blood flow is inadequate to supply the oxygen required by the heart.
3/24/04 Cardiac Inotropic Drugs. 3/24/04 Pathogenesis of congestive heart failure A number of compensatory mechanisms come into play during the development.
Giving our patients the best chance to survive shock Erik Diringer, DO Intensivist – Kenmore Mercy Hospital.
Prof. Azza Hafiz El-Medany Prof. Abdulrahman Al-Motrefi.
Thank you Suanne Daves, MD
HuBio 543 September 26, 2007 Neil M. Nathanson K-536A, HSB Adrenergic Agonists &Other Sympathomimetics.
Heart Failure. Introduction It is the inability of the heart to pump sufficient blood to meet body requirement. HF can be due to 1.Increased preload.
Intensive Care Cardiovascular Pharmacology
 Introduction  Classification of inotropes  Postoperative myocardial dysfunction.  Choice of inotrope  Indications in specific settings.
أ. م. د. وحدة اليوزبكي Head of Department of Pharmacology- College of Medicine- University of Mosul-2014 Management of Heart Failure 2.
Cardiovascular Medication
Drugs used for Congestive Heart Failure
Actions of epinephrine:
CVS PHARMACOLOGY. Drugs to treat myocardial ischemia Etiology 1. Decrease in myocardial oxygen supply [determined by oxygen-carrying capacity of blood.
Overview of Receptors and Drugs
PRESSORS & ANTIHYPERTENSIVES Luis R. Sauceda-Cerda, MD PGY-4.
Adult and Pediatric Emergency Drugs
Heart Failure  Dfinition:  Clinical features  Underlying causes of HF include Arteriosclerotic heart disease, MI, hypertensive heart disease, valvular.
PHARMACOLOGY OF ANTI-ANGINAL DRUGS (ID#580) Dr. Mariam Yousif Pharmacology & Toxicology Dept. November 17 th, 2014.
Vasopressors and Inotropes Critical Care Lecture Series.
Department of Pharmacology
Pharmacology Cardiovascular drugs Part I
CODE BLUE MANAGEMENT DRUG THERAPY
Drugs used for Congestive Heart Failure
Prof. Abdulrahman Al-Motrefi
Drug acting on the Heart
Drugs Affecting the Cardiovascular System
Maya Govender Practice Educator CTICU FCCNC – 25th October 2017
Inotropes & Vasopressors
Anti Anginal Agents Pharmacology Week 10.
Maya Govender Practice Educator CTICU FCCNC – 30th January 2018
2 Cardiovascular Physiology: Function.
Antianginal Drugs.
Drugs Acting on the Heart
Antianginal Drugs Ass. Prof. Naza M. Ali Lec 3-4 G2 21 April 2019
Anti Anginal Agents Pharmacology Week 10.
Recent advances – levosimendan
Presentation transcript:

Common Cardiovascular Drugs

Inotropic agents Vasodilators Antiarrythmic agents

α receptors ↑ protein kinase C  ↑intracellular Ca  smooth muscle contraction β receptor ↑ intracellular cAMP  relax smooth muscle, increase cardiac muscle contractility

α1 : peripheral vascular contraction β1 : increase HR, contractility β2 : 主要vasodilation, bronchodilation; 次要increase HR, contractility

Inotropic agents

Dopamine 因dose (ug/kg/min)的不同而作用在不同的receptor上 1-3  dopaminergic (DA): ↑renal and mesenteric blood flow 3-10  β 為主: increase HR, contractility; decrease SVR, but increase PVR > 10  α 為主: increase SVR and PVR; decrease renal flow

Levophed ( norepinepherine) 以α為主,β1為輔 Increase SVR  increase BP; may increase contractility; increase PVR 4mg/400ml 0.01 ml/ml =10ug/ml Usual range for infusion: 0.05-0.3 ug/kg/min

Dobutrex (dobutamine) β為主 (尤其β1),minimal α effects Increase HR, contractility; decrease SVR, PVR dobutamine is an inotrope but not a pressor ! Infusion dosage: 2-20 ug/kg/min

Milrinone (primacor) Phosphodiesterase inhibitor Inhibit cAMP to breakdown  increase intracellular cAMP concentration In cardiac muscle: increase contractility, HR In vascular smooth muscle: vasodilation; decrease SVR, PVR

Loading dose: 25-75 ug/kg over 1-10 min Infusion dose: 0.375-0.75 ug/kg/min

Bosmin (epinephrine) 因dose (ug/kg/min)不同著重於不同的receptor 0.01-0.03: β 0.03-0.15: β為主,α為輔 > 0.15: α為主,β為輔

For cardiac arrest: adult: 0 For cardiac arrest: adult: 0.5 -1 mg IV bolus pediatric : 5-15 ug/kg IV bolus may be given intratracheally in 1 -10 ml volume Severe allergic reaction or bronchospasm: 10 ug/kg

Vasodilators

Nitroglycerin Direct vasodilator, venous > arterial dilation Mainly preload reduction ; reduce PVR large dose > 10 ug/kg/min produce arteriolar dilation Relieve coronary spasm, increase coronary flow, decrease ischemia

IV bolus: 50-100 ug Infusion: 0.1 – 7 ug/kg/min Nitroderm

Trandate (labetalol) α blocker: β blocker = 1:7 decrease HR; decrease BP Long duration

Perdipine Ca channel blocker Arterial dilation, decrease SVR Mild myocardial depressant: minimal in clinical dosage

PGE1 Selectively dilate the ductus arteriosus in neonates and infants Potent pulmonary vascular vasodilating effects Infusion dosage: 0.05 – 0.4 ug/kg/min

Antiarrythmic agents

Isuprel (isoproterenol) Pure β effect Positive inotropic and chronotropic effects May decrease BP Infusion: 0.02-0.05 ug/kg/min

Esmolol Selective β1 blocker Decrease HR, BP IV: 0.25-0.5 mg/kg Infusion: 50-200 ug/kg/min Rapid elimination

Amiodarone Use in Af, SVT, ventricular arrthymia Loading: 150 mg IV for 10 min Infusion: max. 900-1200mg/24hr first 24 hr, 720mg/24hr next Potent vasodilating effects and negative inotropic effects